These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1270 related articles for article (PubMed ID: 15280342)

  • 1. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
    Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
    Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.
    Green MJ; Peterson SK; Baker MW; Friedman LC; Harper GR; Rubinstein WS; Peters JA; Mauger DT
    Genet Med; 2005 Apr; 7(4):221-9. PubMed ID: 15834239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
    Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
    Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.
    Green MJ; Biesecker BB; McInerney AM; Mauger D; Fost N
    Am J Med Genet; 2001 Sep; 103(1):16-23. PubMed ID: 11562929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
    Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
    Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
    Jacobs AS; Schwartz MD; Valdimarsdottir H; Nusbaum RH; Hooker GW; DeMarco TA; Heinzmann JE; McKinnon W; McCormick SR; Davis C; Forman AD; Lebensohn AP; Dalton E; Tully DM; Graves KD; Similuk M; Kelly S; Peshkin BN
    Fam Cancer; 2016 Oct; 15(4):529-39. PubMed ID: 26969308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor.
    Green MJ; McInerney AM; Biesecker BB; Fost N
    Am J Med Genet; 2001 Sep; 103(1):24-31. PubMed ID: 11562930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
    Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
    Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial.
    Metcalfe KA; Dennis CL; Poll A; Armel S; Demsky R; Carlsson L; Nanda S; Kiss A; Narod SA
    Genet Med; 2017 Mar; 19(3):330-336. PubMed ID: 27584910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
    Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
    BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot trial of a computerized decision aid for breast cancer prevention.
    Ozanne EM; Annis C; Adduci K; Showstack J; Esserman L
    Breast J; 2007; 13(2):147-54. PubMed ID: 17319855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
    Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.